中国实用妇科与产科杂志2017，Vol.33Issue(3)：307-311,5.DOI:10.19538/j.fk2017030117
全盆腔器官切除术治疗晚期或复发妇科恶性肿瘤16例临床分析
Clinical analysis of 16 cases of total pelvic exenteration for patients with advanced or recurrent gynecologic cancer
摘要
Abstract
Objective To evaluate the curative value of total pelvic exenteration in the treatment ot advanced or recurrent gynecologic malignant tumors and access the possible factors associated with outcome and survival.Methods We retrospectively analyzed the records of 16 patients who underwent pelvic exenteration for gynecologic malignancy between April 1995 and April 2012 in our hospital.Results The median duration of follow-up was 37.5 months (range:3～ 157) and the 5-year overall survival rate was 51.6％.Lymph node involvement retained a significant impact on OS and PFS.The other possible prognostic factors were tumor size,surgical margin status,etc.Infective pelvic effusion was the most common complication (37.5％).The severest complications were ileus (25.0％),ureteral anastomosis leak (18.8％) and intestinal anastomosis leaks (6.3％).Conclusion Though post-surgical complications frequently occur,pelvic exenteration is still a safe therapeutic option for advanced or recurrent gynecologic malignancy with high cure rate and little influence on quality of life.But this procedure should be considered in highly selected patients with no unresectable or metastatic diseases.关键词
全盆腔器官联合切除/宫颈恶性肿瘤/并发症Key words
pelvic exenteration/uterine cervical cancer/complications分类
医药卫生引用本文复制引用
邵株燕,闻强,羊正炎,朱笕青,张平..全盆腔器官切除术治疗晚期或复发妇科恶性肿瘤16例临床分析[J].中国实用妇科与产科杂志,2017,33(3):307-311,5.基金项目
浙江省自然科学基金(Y2111317) （Y2111317）
